1 High-Flying Stock with Solid Fundamentals and 2 We Avoid [Yahoo! Finance]
Repligen (RGEN) had its price target raised by HC Wainwright from $180.00 to $208.00. They now have a "buy" rating on the stock.
Repligen Conference: CEO touts differentiated bioprocessing portfolio; CFO targets 30% EBITDA margin [Yahoo! Finance]
Repligen Earnings Beat Puts Focus On Analytics Growth And Rich Valuation [Yahoo! Finance]
A Look Back at Drug Development Inputs & Services Stocks' Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack [Yahoo! Finance]